Correction: Targeting CD93 on monocytes revitalizes antitumor immunity by enhancing the function and infiltration of CD8+ T cells

Correction: Targeting CD93 on monocytes revitalizes antitumor immunity by enhancing the function and infiltration of CD8+ T cells

Saved in:

Bibliographic Details
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-11-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/12/11/e010148corr1.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting CD93 on monocytes revitalizes antitumor immunity by enhancing the function and infiltration of CD8+ T cells
by: Yan Wu, et al.
Published: (2024-10-01)

Bezafibrate-driven mitochondrial targeting enhances antitumor immunity and prevents lung cancer via CD8+ T cell infiltration and MDSC reduction
by: Jing Pan, et al.
Published: (2025-04-01)

Intercellular Mitochondrial Transfer Enhances the Antitumor Immunity of CD8+ T Cells
by: Ce Guo, et al.
Published: (2025-06-01)

CD93 blockade promotes effector T-cell infiltration and facilitates adoptive cell therapy in solid tumors
by: Yi Sun, et al.
Published: (2025-01-01)

Two chemotherapeutic agents expand stem-like CD62L+CD8+ T cells in antitumor immune responses
by: Xiaokang Ruan, et al.
Published: (2025-04-01)

Disruption of cell-intrinsic PCSK9 enhances the antitumor efficacy of CD8+ T cells
by: Zhe Xu, et al.
Published: (2025-07-01)

The significance of CD4+ and CD8+ T lymphocyte infiltration in esophageal squamous cell carcinoma
by: Jiang Y. Zhao, et al.
Published: (2025-01-01)

Piezo1 deletion enhances cross-priming of CD8+ T cells by tumor-infiltrating CD11b+ dendritic cells
by: Tyler E Miller, et al.
Published: (2025-06-01)

Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via strengthening CD8 + TILs function and recruiting B cells in cervical cancer
by: Lili Jiang, et al.
Published: (2025-06-01)

PD-1 blockade employed at the time CD8+ T cells are activated enhances their antitumor efficacy
by: Douglas G McNeel, et al.
Published: (2025-05-01)

Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.
by: Gerik W Tushoski-Alemán, et al.
Published: (2024-01-01)

Correction: Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch
Published: (2021-10-01)

DA-DRD5 signaling reprograms B cells to promote CD8+ T cell-mediated antitumor immunity
by: Yuqing Wu, et al.
Published: (2025-03-01)

Expansion of CD103+CD69+CD8+ cytotoxic liver tissue resident memory T cells and inflammatory monocytes in advanced biliary atresia
by: Freya Sibbertsen, et al.
Published: (2025-06-01)

Prediction of CD8+ T cell infiltration in the tumor microenvironment of HGSOC patients
by: Jia Mai, et al.
Published: (2025-08-01)

Elucidating the synergistic roles of CD4+ T and dendritic cells in antitumor immunity
by: Xiubao Ren
Published: (2025-01-01)

Novel anti-CD73-IL-2v bispecific fusion protein augments antitumor immunity by alleviating immunosuppressive adenosine pathways in CD8+ T cells
by: Kyungwha Lee, et al.
Published: (2025-03-01)

Th17 Cells Exhibit Antitumor Effects in MDS Possibly through Augmenting Functions of CD8+ T Cells
by: Jing Li, et al.
Published: (2016-01-01)

Regulatory T cells define affinity thresholds for CD8+ T cell tumor infiltration
by: Mona O. Mohsen, et al.
Published: (2025-06-01)

TNFR2/CCR8 bispecific antibody enhances antitumor activity through depleting Ti-Tregs and boosting effector CD8+ T cell function
by: Ran Wang, et al.
Published: (2025-12-01)

Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer
by: Meng Zhang, et al.
Published: (2022-03-01)

Nomograms for stratified prognosis prediction of gastric cancer by integrating programmed death ligand 1 and tumor-infiltrating immune cells including CD4+/CD8+ TILs and CD163+ TAMs
by: Xiumin Qi, et al.
Published: (2025-06-01)

Targeting tumor metabolism to augment CD8+ T cell anti-tumor immunity
by: Huan Liu, et al.
Published: (2025-05-01)

CD8+ T-cell lymphocytes infiltration predict clinical outcomes in Wilms’ tumor
by: Keykhosro Mardanpour, et al.
Published: (2020-12-01)

Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset
Published: (2022-03-01)

Enrichment of decidual CD11c + CD8 + T cells with altered immune function in early pregnancy loss
by: Ling Guo, et al.
Published: (2025-07-01)

Knockdown of CSF1R molecules enhances the antitumor effects of CD8+ T lymphocytes in bladder cancer
by: Jingxuan Peng, et al.
Published: (2025-07-01)

CD11b Blockade Ameliorates Myocardial Ischemia/Reperfusion Injury by Reducing Neutrophil and Monocyte Infiltration
by: Peng Fu, et al.
Published: (2025-07-01)

SLAMF7 (CD319) enhances cytotoxic T-cell differentiation and sensitizes CD8+ T cells to immune checkpoint blockade
by: Jan-Erik Sander, et al.
Published: (2025-08-01)

Insight Into the Significance of CD8+ Tumor‐Infiltrating Lymphocytes in Lung Adenocarcinoma
by: Kazu Shiomi, et al.
Published: (2025-07-01)

An oncolytic vaccinia virus expressing anti-CD47 nanobody exerts enhanced antitumor activity by mediating innate and adaptive immune cell infiltration and activation in the lymphoma tumor microenvironment
by: Mengyuan Li, et al.
Published: (2025-04-01)

A CD8+ T Cell Infiltration–Driven Prognostic Signature for Gastric Cancer: Bridging Tumor Immunity and Clinical Outcomes
by: Yiting Qian, et al.
Published: (2025-01-01)

XCL1-secreting CEA CAR-T cells enhance endogenous CD8+ T cell responses to tumor neoantigens to confer a long-term antitumor immunity
by: Kun Chen, et al.
Published: (2025-01-01)

Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2,3-dioxygenase.
by: Mateusz Rytelewski, et al.
Published: (2014-01-01)

Phenotype and functions of human dendritic cells derived from CD14+ monocyte subsets opposed to CD16 expression
by: E. R. Chernykh, et al.
Published: (2019-05-01)

Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity
by: Ping Cheng, et al.
Published: (2024-12-01)

Prognostic relevance of sarcopenia and tumor‐infiltrating CD8+ T cells in patients with hepatocellular carcinoma
by: Shunsuke Doi, et al.
Published: (2025-03-01)

Circulating IL6 is involved in the infiltration of M2 macrophages and CD8+ T cells
by: Jing Huang, et al.
Published: (2025-03-01)

Targeted expansion of cytotoxic T cells using IL-12 and CD137L supplementation enhances antitumor efficacy
by: Marta Sanz, et al.
Published: (2025-06-01)

The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+ and CD8+) on Chemotherapy Response in Colorectal Cancer Patients
by: Lukman K, et al.
Published: (2025-01-01)